Nursing
Departamento
Institute Catalá Oncología
Barcelona, EspañaPublications in collaboration with researchers from Institute Catalá Oncología (2)
2024
2023
-
NLRP3 inflammasome activation and symptom burden in KRAS-mutated CMML patients is reverted by IL-1 blocking therapy
Cell Reports Medicine, Vol. 4, Núm. 12